evocalcet   Click here for help

GtoPdb Ligand ID: 9042

Synonyms: KHK-7580 | MT-4580
PDB Ligand
Compound class: Synthetic organic
Comment: Evocalcet is an investigational calcium-sensing receptor (CASR) agonist, or calcimimetic. CASR is a G protein-coupled receptor.
This compound is claimed in patent US8362274 [2].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 2
Rotatable bonds 6
Topological polar surface area 52.57
Molecular weight 374.2
XLogP 5.08
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES OC(=O)Cc1ccc(cc1)N1CCC(C1)NC(c1cccc2c1cccc2)C
Isomeric SMILES OC(=O)Cc1ccc(cc1)N1CC[C@@H](C1)N[C@@H](c1cccc2c1cccc2)C
InChI InChI=1S/C24H26N2O2/c1-17(22-8-4-6-19-5-2-3-7-23(19)22)25-20-13-14-26(16-20)21-11-9-18(10-12-21)15-24(27)28/h2-12,17,20,25H,13-16H2,1H3,(H,27,28)/t17-,20+/m1/s1
InChI Key RZNUIYPHQFXBAN-XLIONFOSSA-N
References
1. Miyazaki H, Ikeda Y, Sakurai O, Miyake T, Tsubota R, Okabe J, Kuroda M, Hisada Y, Yanagida T, Yoneda H et al.. (2018)
Discovery of evocalcet, a next-generation calcium-sensing receptor agonist for the treatment of hyperparathyroidism.
Bioorg Med Chem Lett, 28 (11): 2055-2060. [PMID:29724589]
2. Miyazaki H, Tsubakimoto J, Yasuda K, Takamuro I, Sakurai O, Yanagida T, Hisada Y. (2013)
Arylalkylamine compound and process for preparing the same.
Patent number: US8362274 B2. Assignee: Mitsubishi Tanabe Pharma Corporation. Priority date: 28/05/2004. Publication date: 29/01/2013.